Abstract
In the search for an MS diagnostic / prognostic biomarker, circulating microRNAs (miRS) have been in the spotlight. In the context of MS pathophysiological mechanism, several inflammatory miRs have been described as potential diagnostic tools but their prognostic usefulness is yet to be determined. We sought to quantify miR-26a and miR-145, serum levels in MS patients and analyse its diagnostic performance in different groups according to clinical features (MS course and disease activity).
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
